The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients

Journal of Hepatology

Volumn 47, Issue 3, 2007, Pages 348-355

  Ahlenstiel, Golo ^a   Nischalke, Hans Dieter ^a   Bueren, Karin ^a   Berg, Thomas ^b   Vogel, Martin ^a   Biermer, Michael ^b   Grünhage, Frank ^a   Sauerbruch, Tilman ^a   Rockstroh, Jürgen ^a   Spengler, Ulrich ^a   Nattermann, Jacob ^a  

^a UNIVERSITY OF BONN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Genetic factors; GNB3; HCV; HCV HIV co infection; Hepatitis C; Polymorphism; Treatment response

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; G PROTEIN BETA 3 GEEN; GENE; GENOTYPE; HEPATITIS C; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; CYTOSINE; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; GTP-BINDING PROTEIN BETA SUBUNITS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RIBAVIRIN; THYMINE; TREATMENT OUTCOME;

EID: 34547444043     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.04.008     Document Type: Article

References (19)

1. Giordano T.P., Kramer J.R., Souchek J., Richardson P., and El-Serag H.B. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 164 (2004) 2349-2354
2. Pineda J.A., Romero-Gomez M., Diaz-Garcia F., et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41 (2005) 779-789
3. Kramer J.R., Giordano T.P., Souchek J., and El-Serag H.B. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 42 (2005) 309-314
4. El-Serag H.B., Giordano T.P., Kramer J., Richardson P., and Souchek J. Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol 3 (2005) 175-183
5. Rockstroh J.K., and Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis 4 (2004) 437-444
6. Qurishi N., Kreuzberg C., Luchters G., et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 362 (2003) 1708-1713
7. Wasmuth H.E., Werth A., Mueller T., et al. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C. Hepatology 40 (2004) 327-334
8. Mueller T., Mas-Marques A., Sarrazin C., et al. Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. J Hepatol 41 (2004) 652-658
9. Siffert W., Rosskopf D., Siffert G., et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18 (1998) 45-48
10. Sarrazin C., Berg T., Weich V., et al. GNB3 C825T polymorphism and response to interferon-alpha/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection. J Hepatol 43 (2005) 388-393
11. Rosskopf D., Koch K., Habich C., et al. Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins. Cell Signal 15 (2003) 479-488
12. Rosskopf D., Manthey I., and Siffert W. Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics 12 (2002) 209-220
13. Ahlenstiel G., Berg T., Woitas R.P., et al. Effects of the CCR5-Delta 32 mutation on antiviral treatment in chronic hepatitis C. J Hepatol 39 (2003) 245-252
14. Hellier S., Frodsham A.J., Hennig B.J., et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38 (2003) 1468-1476
15. Promrat K., McDermott D.H., Gonzalez C.M., et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124 (2003) 352-360
16. Lagging M., Romero A.I., Westin J., et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44 (2006) 1617-16125
17. Virchow S., Ansorge N., Rosskopf D., Rubben H., and Siffert W. The G protein beta3 subunit splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8. Naunyn Schmiedebergs Arch Pharmacol 360 (1999) 27-32
18. Lindemann M., Virchow S., Ramann F., et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett 495 (2001) 82-86
19. Lindemann M., Barsegian V., Siffert W., Ferencik S., Roggendorf M., and Grosse-Wilde H. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination. Virology 297 (2002) 245-252